NCT05163886 Study of Safety, Tolerability, and Biological Activity of LAM-002A in C9ORF72-Associated Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE2
NCT05151471 Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS Status TERMINATED Phase PHASE3
NCT04987671 Pharmacokinetic and Pharmacodynamic Study of AMX0035 in Patients With ALS Status UNKNOWN Phase PHASE1/PHASE2
NCT04948645 A Phase 1 Study to Investigate the Safety and Pharmacokinetics of Fosigotifator in Patients With Amyotrophic Lateral Sclerosis Status TERMINATED Phase PHASE1
NCT04931862 Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD) Status TERMINATED Phase PHASE1/PHASE2
NCT04569084 Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS Status TERMINATED Phase PHASE3
NCT04396873 PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease Status RECRUITING Phase PHASE1
NCT04259255 Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS) Status UNKNOWN Phase N/A
NCT04248465 An Efficacy and Safety Study of Ravulizumab in ALS Participants Status TERMINATED Phase PHASE3
NCT04165850 Open Label Study to Evaluate Ciprofloxacin/Celecoxib Combination in Patients With ALS Status COMPLETED Phase PHASE2
NCT04165824 Safety Study of Oral Edaravone Administered in Subjects With ALS Status COMPLETED Phase PHASE3
NCT04138095 Virtual Reality as an Adjunct to Management of Pain and Anxiety in Palliative Care Status UNKNOWN Phase NA